Artemis Medicare Services Intrinsic Value
Artemis Medicare Services intrinsic value. Artemis Medicare Services (ARTEMISMED) median intrinsic value is ₹574.00 from 10 valuation models (range ₹97–₹810), vs current price ₹324.10 — +77.1% upside (Trading Below Calculated Value), margin of safety 43.5%. Read ARTEMISMED dividend yield for the complete payout history and dividend yield track record.
ARTEMISMED Valuation Methods Summary — DCF, Graham Number & P/E
Artemis Medicare Services intrinsic value across 10 models vs current price ₹324.10 — upside/downside and value range per method. Compare with Artemis Medicare Services valuation methods to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹97.23 | ₹77.78 - ₹116.68 | -70.0% | EPS: ₹7.60, Sector P/E: 12x |
| Book Value Method | asset | ₹588.12 | ₹529.31 - ₹646.93 | +81.5% | Book Value/Share: ₹588.12, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹574.00 | ₹516.60 - ₹631.40 | +77.1% | Revenue/Share: ₹717.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹648.20 | ₹583.38 - ₹713.02 | +100.0% | EBITDA: ₹236.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹810.25 | ₹648.20 - ₹972.30 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹97.23 | ₹87.51 - ₹106.95 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹97.23 | ₹87.51 - ₹106.95 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹648.20 | ₹583.38 - ₹713.02 | +100.0% | ROE: 12.8%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹317.13 | ₹285.42 - ₹348.84 | -2.2% | EPS: ₹7.60, BVPS: ₹588.12 |
| Dividend Yield Method | dividend | ₹97.23 | ₹87.51 - ₹106.95 | -70.0% | DPS: ₹0.45, Target Yield: 3.5% |
ARTEMISMED Intrinsic Value vs Market Price — All Valuation Models
Artemis Medicare Services fair value range ₹97–₹810 vs current market price ₹324.10 across 10 valuation models. For current market price and key ratios, visit Artemis Medicare Services share price today.
ARTEMISMED Intrinsic Value Analysis — Undervalued or Overvalued?
Artemis Medicare Services median intrinsic value ₹574.00, current price ₹324.10 — Trading Below Calculated Value by 77.1%, margin of safety 43.5%.
What is the intrinsic value of ARTEMISMED?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Artemis Medicare Services (ARTEMISMED) is ₹574.00 (median value). With the current market price of ₹324.10, this represents a +77.1% variance from our estimated fair value.
The valuation range spans from ₹97.23 to ₹810.25, indicating ₹97.23 - ₹810.25.
Is ARTEMISMED undervalued or overvalued?
Based on our multi-method analysis, Artemis Medicare Services (ARTEMISMED) appears to be trading below calculated value by approximately 77.1%.
ARTEMISMED Financial Health — Key Ratios vs Industry Benchmarks
Artemis Medicare Services financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.32 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 12.8% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 18.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.80x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ARTEMISMED Cash Flow Quality — Operating & Free Cash Flow
Artemis Medicare Services operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹132 Cr | ₹87 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹156 Cr | ₹-41 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹109 Cr | ₹65 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹127 Cr | ₹48 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹60 Cr | ₹7 Cr | Positive Free Cash Flow | 7/10 |